Cannabigerol (CBG) Gummies Market Global Report 2026

The cannabigerol (cbg) gummies market size has grown exponentially in recent years. It will grow from $0.21 billion in 2025 to $0.26 billion in 2026 at a compound annual growth rate (CAGR) of 22.7%. The expansion during the historical period can be attributed to growing consumer interest in alternative wellness solutions, expansion of legally permitted cannabinoid markets, increasing awareness and interest in minor cannabinoids, rising consumption of cannabinoid-based edible products, and advancements in cannabinoid extraction technologies.

The cannabigerol (cbg) gummies market size is expected to see rapid growth in the next few years. It will grow to $0.53 billion in 2030 at a compound annual growth rate (CAGR) of 19.7%. The growth in the forecast period can be attributed to increasing demand for targeted health and wellness solutions, expansion of regulated cannabis markets, growing emphasis on product transparency and accurate labeling, rising investment in cannabinoid research, and increasing consumer preference for gummies as a convenient delivery format. Major trends in the forecast period include growing demand for functional cannabinoid edibles, rising popularity of non-psychoactive wellness products, expansion of flavor-enhanced CBG gummies, increasing emphasis on accurate and consistent dosage formats, and greater focus on naturally sourced ingredients.

The increasing prevalence of anxiety is expected to drive the growth of the cannabigerol (CBG) gummies market. Anxiety is a psychological condition involving persistent or excessive feelings of worry, fear, and nervousness, which can also be accompanied by physical symptoms such as sweating and heart palpitations. The prevalence of anxiety is rising due to factors including stress, traumatic experiences, genetic influences, and environmental conditions. Cannabigerol (CBG) gummies are marketed for anxiety because CBG may interact with the endocannabinoid system and influence neurotransmitter activity, potentially supporting relaxation and stress management. For instance, in February 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, an estimated 2,261,100 Australian males, equivalent to 23% of the male population, and 3,429,300 females, equivalent to 34% of the female population, aged 16 to 85 had experienced an anxiety disorder at some point in their lives. Therefore, the increasing prevalence of anxiety is expected to propel the growth of the cannabigerol (CBG) gummies market.

Key companies operating in the cannabigerol (CBG) gummies market are developing innovative products, such as gummies formulated with natural ingredients, to address the growing demand for wellness-focused cannabinoid products. Gummies with natural ingredients are products manufactured using organic and plant-based components, providing a wholesome and pure consumption experience. For example, in November 2023, Rare Cannabinoid Company, a health and wellness company, launched THC + CBG Relief Gummies, a distinctive combination of Delta-9-THC, CBG, and CBD designed to naturally support physical well-being. These gummies combine the benefits of THC Gummies and CBG Gummies with the complementary benefits of CBD. Each green apple-flavored gummy contains 2.5mg of Delta-9-THC, 30mg of CBG, and 10mg of CBD. With 30 gummies included in each bottle, the product provides a convenient and enjoyable option for consumers seeking to explore the potential benefits of these cannabinoids.

In October 2024, Canopy Growth, a Canada-based cannabis company, acquired Wana for an undisclosed amount. Through this acquisition, Canopy USA aims to reinforce its position as a leading brand-oriented cannabis company in the U.S. while broadening its product portfolio across state-legal cannabis markets and hemp-derived products. Wana is a U.S.-based cannabis company focused on developing innovative edible and ready-to-drink hemp-derived products, including Delta-9-THC and non-intoxicating CBD gummies.

Major companies operating in the cannabigerol (cbg) gummies market are Demetrix Inc., Rare Cannabinoid Company, CanniLabs, Vida Optima LLC, Curaleaf Holding Inc., The Cronos Group, Charlotte's Web Holdings Inc., Hemptown USA Inc., Green Roads LLC, Lazarus Naturals Inc., Medterra CBD LLC, ENDOCA, Extract Labs, NuLeaf Naturals LLC, Isodiol International Inc., CBDistillery, Elixinol Wellness Ltd., Joy Organics, CBD American Shaman, Steves Goods, Incredibles Edibles, Sunday Scaries, CannaCare Health GmbH, FAB Nutrition LLC (FAB CBD)

North America was the largest region in the cannabigerol (CBG) gummies market in 2025. The regions covered in the cannabigerol (cbg) gummies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cannabigerol (cbg) gummies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

This product will be delivered within 1-3 business days.